Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06813287 · ClinicalTrials.gov registry record · Phase 2
Brain Monitoring, tDCS and Robotic Training in SCI
A Phase 2 study, sponsored by Kathleen Friel.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT06813287: Completed Phase 2 study, sponsored by Kathleen Friel.
NCT06813287 is a Phase 2 study that has completed, run by Kathleen Friel. The registered enrollment target is 17 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06813287, a Phase 2 study, has completed, sponsored by Kathleen Friel.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
To explore the neurophysiological and electroencephalography (EEG) changes that one single session of tDCS and robotics has in the SCI population (Study 1); and to investigate upper limb motor recovery in chronic tetraplegia SCI patients, comparing two rehabilitation strategies: real or sham tDCS combined with upper-limb robotic therapy (Study 2), as well as to characterize the neurophysiological (TMS) and brain signaling (EEG) profile of patients and specific muscles that respond to the combination of neuromodulation and robotic motor training.
Primary Outcome
The necessary stimulator output to evoke a response in the target muscle
Interventions
- DIAGNOSTIC_TEST Electroencephalography (EEG)
- DEVICE Upper extremity robot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-11-01 |
| Est. Completion | 2018-06-27 |
| Phase | Phase 2 |
What the finished NCT06813287 record still lists
NCT06813287 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Electroencephalography (EEG) is the first listed.
NCT06813287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06813287 about?
NCT06813287 is a clinical study titled "Brain Monitoring, tDCS and Robotic Training in SCI". To explore the neurophysiological and electroencephalography (EEG) changes that one single session of tDCS and robotics has in the SCI population (Study 1); and to investigate upper limb motor recovery in chronic tetraplegia SCI patients, comparing two rehabilitation strategies: real or sham tDCS co...
What is the current status of trial NCT06813287?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2012-11-01. Estimated completion is 2018-06-27.
What interventions are being tested in trial NCT06813287?
The interventions under investigation include: Electroencephalography (EEG) (DIAGNOSTIC_TEST), Upper extremity robot (DEVICE).
Who is sponsoring clinical trial NCT06813287?
This trial is sponsored by Kathleen Friel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06813287's enrollment target sits among peer trials
17 1903rd of 2000 higher than 93 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI